🕵️ Bioxcel Therapeutics, Inc. ($BTAI)
SEC insider & ownership activity, last 12 months · CIK 1720893 · every row links its SEC filing
Over the last 12 months insiders sold $43K with no open-market buying against it. Mehta Vimal sold $21K through a 10b5-1 trading plan in 1 lots (May). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 4 sellers, $43K (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Mehta Vimal | 0 | – | 1 | $21K | May 20, 2026 |
| Yocca Frank | 0 | – | 1 | $7K | May 20, 2026 |
| Richard I. Steinhart | 0 | – | 1 | $7K | May 20, 2026 |
| Rodriguez Javier | 0 | – | 1 | $7K | May 20, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Integrated CORE Strategies (US) LLC | 8.4% | 13G | Feb 9, 2026 | filing ↗ | |
| Millennium Management LLC | 8.4% | 13G | Feb 9, 2026 | filing ↗ | |
| Millennium Group Management LLC | 8.4% | 13G | Feb 9, 2026 | filing ↗ | |
| Israel A. Englander | 8.4% | 13G | Feb 9, 2026 | filing ↗ | |
| Armistice Capital, LLC | 7.0% | 13G | May 15, 2026 | filing ↗ | |
| Steven Boyd | 7.0% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Mehta Vimal | $21K | May 20, 2026 | filing ↗ |
| Rodriguez Javier | $7K | May 20, 2026 | filing ↗ |
| Yocca Frank | $7K | May 20, 2026 | filing ↗ |
| Richard I. Steinhart | $7K | May 20, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 6, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 15, 2026 | filing ↗ |
| Other events (8.01) | Apr 1, 2026 | filing ↗ |
| Earnings (2.02) | Mar 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 27, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing ↗ |
| Other events (8.01) | Feb 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 4, 2026 | filing ↗ |
| Other events (8.01) | Jan 20, 2026 | filing ↗ |
| Other events (8.01) | Jan 12, 2026 | filing ↗ |
| Shareholder vote (5.07) | Dec 12, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Other events (8.01) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Other events (8.01) | Oct 30, 2025 | filing ↗ |
| Other events (8.01) | Oct 14, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 15, 2025 | filing ↗ |
| Other events (8.01) | Sep 15, 2025 | filing ↗ |
| Other events (8.01) | Sep 10, 2025 | filing ↗ |
| Other events (8.01) | Aug 27, 2025 | filing ↗ |
| Other events (8.01) | Aug 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 18, 2025 | filing ↗ |
| Other events (8.01) | Aug 18, 2025 | filing ↗ |